Table 1.
Variable | Patients With 0–1 Prognostic factors (n=576) |
Patients With 2–3 Prognostic Factors (n=636) |
P value |
---|---|---|---|
Age (years) (mean±SD) | 60±9 | 60±9 | 0.961 |
Female (n (%)) | 90 (16%) | 58 (9%) | <0.001 |
White race (n (%)) | 390 (68%) | 437 (69%) | 0.708 |
Body mass index (mean±SD) | 27±5 | 27±5 | 0.683 |
History of previous myocardial infarction (n (%)) | 436 (76%) | 498 (78%) | 0.281 |
Atrial flutter or fibrillation (n (%)) | 58 (10%) | 95 (15%) | 0.011 |
Previous CABG (n (%)) | 10 (2%) | 26 (4%) | 0.016 |
Previous PCI (n (%)) | 68 (12%) | 88 (14%) | 0.292 |
Advanced angina* (n (%)) | 33 (6%) | 25 (4%) | 0.143 |
Advanced heart failure† (n (%)) | 179 (31%) | 268 (42%) | <0.001 |
Three-Vessel CAD (n (%)) | 289 (50%) | 445 (70%) | <0.001 |
Moderate or severe mitral regurgitation (n (%)) | 83 (14%) | 137 (22%) | 0.001 |
LV EF (%) (mean±SD) | 34±7 | 23±5 | n/a |
ESVI‡ (ml/m2) (mean±SD) | 61±16 | 104±30 | n/a |
EDVI§ (ml/m2) (mean±SD) | 92±24 | 139±37 | n/a |
Patients randomized to CABG (n (%)) | 274 (48%) | 336 (53%) | 0.067 |
Canadian Cardiac Society Class III or IV
New York Heart Association Functional Class III or IV
End-systolic volume index
End-diastolic volume index